Serum Afamin a Novel Marker of Increased Hepatic Lipid Content

AIM: Afamin is a liver-produced glycoprotein, a potential early marker of metabolic syndrome. Here we investigated regulation of afamin in a course of the metabolic disease development and in response to 3-month exercise intervention. METHODS: We measured whole-body insulin sensitivity (euglycemic h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurdiova, Timea, Balaz, Miroslav, Kovanicova, Zuzana, Zemkova, Erika, Kuzma, Martin, Belan, Vitazoslav, Payer, Juraj, Gasperikova, Daniela, Dieplinger, Hans, Ukropcova, Barbara, Ukropec, Jozef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481912/
https://www.ncbi.nlm.nih.gov/pubmed/34603196
http://dx.doi.org/10.3389/fendo.2021.670425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481912/
https://www.ncbi.nlm.nih.gov/pubmed/34603196
http://dx.doi.org/10.3389/fendo.2021.670425

Ejemplares similares